This is Ampath

We are actively committed to upholding our status as one of Southern Africa’s foremost pathology laboratories.


We consistently serve the medical fraternity, insurance, governmental, managed health care, industrial organisations and other pathology practices with quality results and careful attention to our client and patient requirements. Ampath performs a full range of clinical analyses – from the routine to the highly esoteric – all under the direction of more than 140 pathologists. We pursue excellence by threading value and integrity throughout our organization all in the name of improving healthcare outcomes.


Ampath is the trading name for a group of amalgamated pathology practices that previously functioned independently and subsequently joined to form the incorporated practices' of Drs Du Buisson, Kramer, Swart and Bouwer.



As is expected during the influenza season, there has been a marked increase in cases of influenza in the community as well as people

Read More

Confirmed case of Ebola Virus Disease in Uganda and implications for South Africa

13 June, 2019 The Ugandan Ministry of Health (UMoH) and the World Health Organization (WHO) have confirmed a case

Read More

No Influenza outbreak in South Africa

The 2019 South African influenza season, which started towards the end of April, is ongoing. Transmission of influenza has reached

Read More

Latest News

AmpathChat #55 - Tissue typing: HLA typing and screening

Ampath Immunology is proud to announce the introduction of HLA tissue typing and antibody screening using Luminex PCR-based multiplex technology.

Read More

AmpathChat #54 - Helicobacter pylori: an update

Helicobacter pylori is a highly prevalent curved gram-negative bacterium. Seropositivity rates in South-Africa range between 60% and 100%. It causes more than 90% of duodenal ulcers and up to 80% of gastric ulcers. Atrophic gastritis due to H. pylori can lead to gastric cancer.

Read More

AmpathChat #53 - Molecular testing in colorectal carcinoma

Colorectal carcinomas arise from colorectal epithelium, which has undergone a series of molecular changes, referred to as the adenoma-carcinoma progression sequence.4 With increasing genetic mutations, progression from normal epithelium to adenomas with dysplasia occurs. Eventually, adenomas that show high-grade dysplasia give rise to invasive colorectal carcinomas.

Read More